Juvenile idiopathic arthritis (JIA) is the most common inflammatory joint condition of
childhood and represents seven JIA subtypes characterised by distinct clinical and …

Abstract Purpose of Review To summarize the current evidence on the adoption of the treat-
to-target (T2T) strategy in pediatric rheumatic diseases (PRD). Recent Findings The recent …

Background Juvenile idiopathic arthritis (JIA) is a heterogeneous disease, the signs and
symptoms of which can be summarised with use of composite disease activity measures …

Background Pain is one of the most frequently reported experiences amongst children with
Juvenile Idiopathic Arthritis (JIA); however, the management of JIA pain remains …

A treat-to-target approach is gaining ground as an effective and efficient strategy for a range
of rheumatic diseases (1–4). It is assumed that a treatment continuously aimed at a single …

Pain is the most debilitating symptom in juvenile idiopathic arthritis. As pain correlates poorly
to the extent of joint pathology, therapies that control joint inflammation are often inadequate …

Rheumatoid arthritis (RA) is an example of human chronic inflammatory pain. Modern
treatments suppress inflammation, yet pain remains a major problem for many people with …

Background The aim of this study was to compare pain-scores in three targeted treatment-
strategies in JIA-patients and to identify characteristics predicting persistent pain. Methods In …

Abstract In 2018, an international Task Force formulated recommendations for treating
Juvenile Idiopathic Arthritis (JIA) to target. The Task Force has not yet resolved three issues …

Objective To study self‐reported pain early in the disease course of juvenile idiopathic
arthritis (JIA) as a predictor of long‐term disease outcomes. Methods Consecutive cases of …